Understanding diffuse leptomeningeal glioneuronal tumors

Area of Science:

• Pediatric neuro-oncology
• Central nervous system neoplasms
• Molecular pathology

Background:

• Diffuse leptomeningeal glioneuronal tumors (DLGNTs) are rare and challenging pediatric central nervous system neoplasms.
• DLGNTs present complex clinical and molecular features requiring deeper understanding.

Purpose of the Study:

• To synthesize current literature on DLGNTs.
• To provide comprehensive overview of epidemiology, clinical presentation, pathology, treatment, and prognosis.

Main Methods:

• Comprehensive literature search of relevant databases.
• Review of contemporary studies on DLGNTs.

Main Results:

• DLGNTs affect all ages, primarily pediatric populations, with nonspecific symptoms and overlapping imaging features.
• MRI is key for diagnosis, showing leptomeningeal enhancement and intraparenchymal involvement.
• Histology shows low-moderate cellularity with MAPK/ERK pathway alterations; management requires a multidisciplinary approach including surgery, chemo, radiation, and targeted therapies.

Conclusions:

• Advancements in molecular profiling and targeted therapies offer hope for improved DLGNT outcomes.
• International collaboration and multidisciplinary expertise are crucial for advancing DLGNT research and patient care.